#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	998	CRP	633	633	99.53	CRP.l15.c4.ctg.1	1125	47.4	0	.	p	.	0	K29T	NONSYN	85	87	AAG	341	343	ACG	55;54;49	A;C;G	55;53;49	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3916	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1400	137.0	1	SNP	p	R234F	1	.	.	700	702	TTC	889	891	TTC	208;207;204	T;T;C	207;206;203	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3916	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1400	137.0	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1189	1191	CGT	179;180;180	C;G;T	179;180;178	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3916	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1400	137.0	0	HET	.	.	.	T180C,A	.	180	180	T	369	369	T	100	T,C,A	52,42,1	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3916	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1400	137.0	0	HET	.	.	.	C261T	.	261	261	C	450	450	C	159	C,T	81,76	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3916	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1400	137.0	0	HET	.	.	.	T999C	.	999	999	T	1188	1188	T	174	T,C	92,82	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3916	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1400	137.0	0	HET	.	.	.	T90C	.	90	90	T	279	279	T	86	T,C	56,30	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3916	Escherichia_coli_EF_Tu	1230	71	100.0	Escherichia_coli_EF_Tu.l15.c30.ctg.3	213	16.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1092	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c4.ctg.1	1825	31.9	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1580	1582	AAA	12;11;11	A;A;A	12;11;11	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1924	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l6.c30.ctg.1	1823	56.5	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1253	1255	GAA	58;58;58	G;A;A	58;58;58	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	288	H_NS	414	414	99.03	H_NS.l15.c4.ctg.1	708	21.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	T1041G	SNP	1041	1041	T	12	12	G	187	G	134	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	A1042T	SNP	1042	1042	A	13	13	T	192	T,G	138,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	A1136G	SNP	1136	1136	A	107	107	G	324	G	323	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	T1138C	SNP	1138	1138	T	109	109	C	311	C	310	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	T1142C	SNP	1142	1142	T	113	113	C	273	C	271	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	C1170T	SNP	1170	1170	C	141	141	T	235	T	234	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	T1220C	SNP	1220	1220	T	191	191	C	223	C	222	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	T1245C	SNP	1245	1245	T	216	216	C	185	C	184	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	G1253A	SNP	1253	1253	G	224	224	A	208	A	208	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	G1256A	SNP	1256	1256	G	227	227	A	215	A	215	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	C1258A	SNP	1258	1258	C	229	229	A	218	A	218	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	G1266T	SNP	1266	1266	G	237	237	T	243	T	238	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	T1267C	SNP	1267	1267	T	238	238	C	247	C	246	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	T1275C	SNP	1275	1275	T	246	246	C	241	C	241	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	G1276A	SNP	1276	1276	G	247	247	A	240	A	238	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	A1281G	SNP	1281	1281	A	252	252	G	231	G	230	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	T1283C	SNP	1283	1283	T	254	254	C	238	C	237	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	G1288T	SNP	1288	1288	G	259	259	T	261	T	260	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	A1296G	SNP	1296	1296	A	267	267	G	324	G	320	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	T1299G	SNP	1299	1299	T	270	270	G	331	G	330	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	A1300T	SNP	1300	1300	A	271	271	T	334	T	334	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	C1356T	SNP	1356	1356	C	327	327	T	232	T	230	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	A1358G	SNP	1358	1358	A	329	329	G	215	G	212	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	T1368C	SNP	1368	1368	T	339	339	C	195	C	195	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	G1370A	SNP	1370	1370	G	341	341	A	188	A	188	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	C1406.	DEL	1406	1406	C	376	376	C	138	C	138	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	.1409C	INS	1409	1409	T	380	380	C	128	C	128	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	C1431A	SNP	1431	1431	C	402	402	A	8	A	8	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	C1432A	SNP	1432	1432	C	403	403	A	8	A	8	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	A1441G	SNP	1441	1441	A	412	412	G	9	G	9	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	T1464C	SNP	1464	1464	T	435	435	C	24	C	24	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	G1473T	SNP	1473	1473	G	444	444	T	108	T	108	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	A1475G	SNP	1475	1475	A	446	446	G	123	G	121	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	.	n	.	0	A1548T	SNP	1548	1548	A	519	519	T	120	T	120	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	1	SNP	n	C1194G	0	.	.	1194	1194	C	165	165	C	232	C	231	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4914	Pasteurella_multocida_16S	1551	522	91.59	Pasteurella_multocida_16S.l15.c30.ctg.1	773	175.3	0	HET	.	.	.	C1040T	.	1040	1040	T	11	11	C	167	C,T	83,31	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1390	PmrB_1	1092	1092	99.27	PmrB_1.l15.c30.ctg.1	1530	48.6	0	.	p	.	0	H2R	NONSYN	4	6	CAT	235	237	CGT	41;38;38	C;G;T	40;37;38	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1390	PmrB_1	1092	1092	99.27	PmrB_1.l15.c30.ctg.1	1530	48.6	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1078	1080	GGC	64;65;64	G;G;C	64;65;64	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1972	PmrC	1644	1644	99.15	PmrC.l15.c17.ctg.1	2053	51.6	0	.	p	.	0	R8S	NONSYN	22	24	AGA	266	268	AGC	16;17;19	A;G;C	16;16;19	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1972	PmrC	1644	1644	99.15	PmrC.l15.c17.ctg.1	2053	51.6	0	.	p	.	0	I142L	NONSYN	424	426	ATA	668	670	CTA	45;48;50	C;T,A;A	44;47,1;50	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1972	PmrC	1644	1644	99.15	PmrC.l15.c17.ctg.1	2053	51.6	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1187	1189	CAA	75;74;73	C;A;A	75;74;73	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1972	PmrC	1644	1644	99.15	PmrC.l15.c17.ctg.1	2053	51.6	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1286	1288	GGT	95;93;91	G;G;T	95;93;91	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1972	PmrC	1644	1644	99.15	PmrC.l15.c17.ctg.1	2053	51.6	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1856	1858	GTT	31;31;31	G;T;T	31;31;31	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	788	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1621	26.1	0	.	p	.	0	A125E	NONSYN	373	375	GCA	604	606	GAA	31;30;29	G;A;A	31;30;29	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	788	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1621	26.1	0	.	p	.	0	M185T	NONSYN	553	555	ATG	784	786	ACC	11;10;10	A;C;C	11;10;10	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	788	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1621	26.1	0	.	p	.	0	S225T	NONSYN	673	675	TCC	904	906	ACT	32;34;34	A;C;T	32;34;34	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	788	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1621	26.1	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1294	1296	ATC	14;14;15	A;T;C	14;14;15	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	968	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1413	36.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2838	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3589	42.3	0	.	p	.	0	T85I	NONSYN	253	255	ACC	524	526	ATC	44;44;42	A;T;C	43;44;41	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2838	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3589	42.3	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2237	2239	AAG	30;30;30	A;A;G	30;30;30	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1396	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1590	47.1	0	.	p	.	0	A22V	NONSYN	64	66	GCC	269	271	GTC	9;9;9	G;T;C	9;9;9	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1396	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1590	47.1	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1010	1012	TGC	67;70;70	T;G;C	67;69;69	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3524	acrF	3105	3105	98.78	acrF.l15.c17.ctg.1	3362	55.7	0	.	p	.	0	S46trunc	TRUNC	136	136	T	308	308	T	35	T	35	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3524	acrF	3105	3105	98.78	acrF.l15.c17.ctg.1	3362	55.7	0	.	p	.	0	G148D	NONSYN	442	444	GGC	614	616	GAC	53;53;55	G;A;C	52;52;54	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3524	acrF	3105	3105	98.78	acrF.l15.c17.ctg.1	3362	55.7	0	.	p	.	0	F240L	NONSYN	718	720	TTT	890	892	TTA	25;25;26	T;T;A	25;25;26	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3524	acrF	3105	3105	98.78	acrF.l15.c17.ctg.1	3362	55.7	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	1967	1969	AAT	64;65;63	A;A;T	64;65;63	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3524	acrF	3105	3105	98.78	acrF.l15.c17.ctg.1	3362	55.7	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	2081	2083	AGT	61;60;58	A;G;T	61;59;57	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3524	acrF	3105	3105	98.78	acrF.l15.c17.ctg.1	3362	55.7	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2480	2482	GTG	42;42;43	G;T;G	41;41;42	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3524	acrF	3105	3105	98.78	acrF.l15.c17.ctg.1	3362	55.7	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	3035	3037	AAG	57;55;55	A;A;G	57;55;55	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	650	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1064	32.7	1	SNP	p	R45C	0	.	.	133	135	CGC	338	340	CGC	57;55;52	C;G;C	55;55;52	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	686	acrS	663	663	98.79	acrS.l15.c30.ctg.1	943	38.3	0	.	p	.	0	L34F	NONSYN	100	102	CTC	178	180	TTC	32;32;32	T;T;C	32;32;32	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	686	acrS	663	663	98.79	acrS.l15.c30.ctg.1	943	38.3	0	.	p	.	0	E122G	NONSYN	364	366	GAG	442	444	GGG	29;29;32	G;G;G	28;28;32	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	920	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1207	40.9	0	.	p	.	0	V136L	NONSYN	406	408	GTT	636	638	CTT	60;61;62	C;T;T	60;61;62	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3194	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3094	55.3	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2100	2102	GCA	75;74;75	G;C;A	74;72;75	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3194	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3094	55.3	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2361	2363	ACC	74;78;78	A;C;C	74;78;78	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3194	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3094	55.3	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2670	2672	GCC	47;45;44	G;C;C	47;44;43	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1490	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2355	33.7	0	.	p	.	0	G37A	NONSYN	109	111	GGT	220	222	GCT	9;9;9	G;C;T	9;9;9	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1490	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2355	33.7	0	.	p	.	0	D77E	NONSYN	229	231	GAT	340	342	GAG	15;13;12	G;A;G	15;13;12	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1490	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2355	33.7	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	376	378	TGC	16;16;16	T;G;C	15;15;15	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1490	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2355	33.7	0	.	p	.	0	I150V	NONSYN	448	450	ATT	559	561	GTT	36;38;39	G;T;T	36;38;39	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1490	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2355	33.7	0	.	p	.	0	R200H	NONSYN	598	600	CGC	709	711	CAC	25;25;23	C;A;C	25;25;23	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1490	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2355	33.7	0	.	p	.	0	T295M	NONSYN	883	885	ACG	994	996	ATG	55;55;56	A;T;G	55;54;56	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1490	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2355	33.7	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1990	1992	CGC	32;31;33	C;G;C	32;31;33	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	680	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1245	29.0	0	.	p	.	0	S221T	NONSYN	661	663	AGC	875	877	ACC	9;8;9	A;C;C	9;8;9	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	680	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1245	29.0	0	.	p	.	0	P225S	NONSYN	673	675	CCG	887	889	TCG	17;17;17	T;C;G	17;17;17	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	539	602	baeR	723	723	97.65	baeR.l15.c4.ctg.1	1032	30.9	0	.	p	.	0	S214F	NONSYN	640	642	TCT	857	859	TTT	21;21;20	T;T;T	20;21;20	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1072	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1618	34.1	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1328	1330	AAA	12;12;12	A;A;A	12;12;12	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1072	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1618	34.1	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1340	1342	GAG	15;16;16	G;A;G	13;15;15	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1072	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1618	34.1	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1346	1348	CAC	15;16;17	C;A;C	14;16;17	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1072	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1618	34.1	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1400	1402	GAG	29;28;27	G;A;G	29;28;27	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	539	1566	cpxA	1374	1374	98.76	cpxA.l6.c4.ctg.1	1808	46.2	0	.	p	.	0	A231T	NONSYN	691	693	GCG	902	904	ACG	41;42;42	A;C;G	40;42;42	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	1060	cpxR	699	699	99.43	cpxR.l15.c30.ctg.1	1198	47.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	838	cysB	975	975	99.28	cysB.l6.c30.ctg.1	1469	30.6	0	.	p	.	0	T132I	NONSYN	394	396	ACA	646	648	ATA	44;44;45	A;T;A	44;44;45	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1160	emrA	1173	1173	98.38	emrA.l15.c4.ctg.1	1647	37.8	0	.	p	.	0	I219V	NONSYN	655	657	ATC	864	866	GTC	64;60;59	G;T;C	63;59;58	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	1698	emrB	1539	1539	99.81	emrB.l6.c30.ctg.1	2016	45.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1310	emrD	1191	1191	98.57	emrD.l15.c4.ctg.1	1672	42.1	0	.	p	.	0	G209S	NONSYN	625	627	GGC	869	871	AGC	30;31;27	A;G;C	30;31;27	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	40	emrE_1	333	140	92.86	emrE_1.l6.c30.ctg.1	152	2.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	774	emrK	1056	1056	98.2	emrK.l15.c17.ctg.1	1499	27.6	0	.	p	.	0	K176R	NONSYN	526	528	AAG	749	751	AGG	26;26;28	A;G;G	26;26;28	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	774	emrK	1056	1056	98.2	emrK.l15.c17.ctg.1	1499	27.6	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1139	1141	GAC	22;21;22	G;A;C	22;21;22	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	622	emrR	531	531	100.0	emrR.l15.c4.ctg.1	986	33.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	1136	emrY	1539	1539	99.81	emrY.l6.c30.ctg.1	1992	30.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	500	evgA	615	615	99.19	evgA.l15.c30.ctg.1	1070	25.0	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	407	409	CTG	29;29;28	C;T;G	29;29;27	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2616	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4126	34.0	0	.	p	.	0	T38I	NONSYN	112	114	ACA	353	355	ATA	14;13;12	A;T;A	14;13;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2616	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4126	34.0	0	.	p	.	0	L42V	NONSYN	124	126	CTA	365	367	GTA	13;12;13	G;T;A	13;12;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2616	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4126	34.0	0	.	p	.	0	A93T	NONSYN	277	279	GCG	518	520	ACG	24;24;26	A;C;G	24;24;26	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2616	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4126	34.0	0	.	p	.	0	A114E	NONSYN	340	342	GCA	581	583	GAA	23;24;24	G;A;A	23;24;23	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2616	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4126	34.0	0	.	p	.	0	T127A	NONSYN	379	381	ACT	620	622	GCT	38;39;38	G,T;C;T	36,1;38;36	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2616	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4126	34.0	0	.	p	.	0	N133D	NONSYN	397	399	AAT	638	640	GAT	40;36;36	G,A;A;T,A	39,1;36;35,1	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2616	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4126	34.0	0	.	p	.	0	P162S	NONSYN	484	486	CCA	725	727	TCA	27;27;26	T;C;A	27;27;26	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2616	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4126	34.0	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	854	856	CAG	15;15;15	C;A;G	15;15;15	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2616	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4126	34.0	0	.	p	.	0	I251V	NONSYN	751	753	ATT	992	994	GTT	24;22;24	G;T;T	24;22;24	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2616	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4126	34.0	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1148	1150	GAT	15;15;15	G;A;T	15;15;15	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2616	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4126	34.0	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1316	1318	AAT	9;8;7	A;A;T	9;8;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2616	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4126	34.0	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1337	1339	TTA	1;1;1	T;T;A	1;1;1	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2616	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4126	34.0	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1538	1540	AAA	21;23;23	A;A;A	21;23;23	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2616	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4126	34.0	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2273	2275	CAT	25;24;24	C;A;T	25;24;24	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2616	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4126	34.0	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2327	2329	CAT	16;16;17	C;A;T	16;16;17	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2616	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4126	34.0	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2345	2347	AGA	22;22;22	A;G;A	22;22;22	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2616	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4126	34.0	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2360	2362	AAT	30;30;29	A;A;T	30;30;29	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2616	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4126	34.0	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2507	2509	TCC	21;22;22	T;C;C	21;22;22	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2616	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4126	34.0	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2672	2674	ATT	22;22;22	A;T;T	22;22;22	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2616	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4126	34.0	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2693	2695	GAT	29;31;31	G;A;T	29;31;30	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2616	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4126	34.0	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2807	2809	GTT	43;41;39	G;T;T	43;41;39	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2616	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4126	34.0	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3092	3094	CAC	43;44;46	C;A;C	42;44;46	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	876	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1307	35.8	1	SNP	p	P64A	0	.	.	190	192	CCA	407	409	CCA	71;70;73	C;C;A	71;70;71	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	876	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1307	35.8	1	SNP	p	P64S	0	.	.	190	192	CCA	407	409	CCA	71;70;73	C;C;A	71;70;71	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	876	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1307	35.8	1	SNP	p	P64R	0	.	.	190	192	CCA	407	409	CCA	71;70;73	C;C;A	71;70;71	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	876	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1307	35.8	1	SNP	p	P64L	0	.	.	190	192	CCA	407	409	CCA	71;70;73	C;C;A	71;70;71	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	876	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1307	35.8	1	SNP	p	P64H	0	.	.	190	192	CCA	407	409	CCA	71;70;73	C;C;A	71;70;71	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	598	gadE	528	528	100.0	gadE.l15.c4.ctg.1	962	33.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	176	gadW	729	231	96.1	gadW.l15.c30.ctg.1	262	21.6	0	.	p	.	0	S234A	NONSYN	700	702	TCG	202	204	GCG	8;8;8	G;C;G	8;8;7	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	734	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1298	30.3	0	.	p	.	0	F53L	NONSYN	157	159	TTC	375	377	TTA	37;35;37	T;T;A	37;35;37	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	734	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1298	30.3	0	.	p	.	0	V79I	NONSYN	235	237	GTT	453	455	ATT	24;26;26	A;T;T	24;26;26	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	734	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1298	30.3	0	.	p	.	0	R246G	NONSYN	736	738	AGA	954	956	GGA	31;30;30	G;G;A	31;30;30	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	734	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1298	30.3	0	.	p	.	0	S248P	NONSYN	742	744	TCG	960	962	CCG	31;31;31	C;C;G	31;31;31	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2852	gyrA_7	2628	2628	98.71	gyrA_7.l15.c17.ctg.1	3113	49.1	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2298	2300	GAA	50;52;53	G;A;A	50;51;53	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2852	gyrA_7	2628	2628	98.71	gyrA_7.l15.c17.ctg.1	3113	49.1	1	SNP	p	S83W	0	.	.	247	249	TCG	513	515	TCG	51;50;51	T;C;G	51;48;51	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2852	gyrA_7	2628	2628	98.71	gyrA_7.l15.c17.ctg.1	3113	49.1	1	SNP	p	S83I	0	.	.	247	249	TCG	513	515	TCG	51;50;51	T;C;G	51;48;51	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2852	gyrA_7	2628	2628	98.71	gyrA_7.l15.c17.ctg.1	3113	49.1	1	SNP	p	S83L	0	.	.	247	249	TCG	513	515	TCG	51;50;51	T;C;G	51;48;51	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2852	gyrA_7	2628	2628	98.71	gyrA_7.l15.c17.ctg.1	3113	49.1	1	SNP	p	D87N	0	.	.	259	261	GAC	525	527	GAC	51;52;51	G;A;C	48;48;51	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2852	gyrA_7	2628	2628	98.71	gyrA_7.l15.c17.ctg.1	3113	49.1	1	SNP	p	D87V	0	.	.	259	261	GAC	525	527	GAC	51;52;51	G;A;C	48;48;51	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2852	gyrA_7	2628	2628	98.71	gyrA_7.l15.c17.ctg.1	3113	49.1	1	SNP	p	D87G	0	.	.	259	261	GAC	525	527	GAC	51;52;51	G;A;C	48;48;51	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2852	gyrA_7	2628	2628	98.71	gyrA_7.l15.c17.ctg.1	3113	49.1	1	SNP	p	D87Y	0	.	.	259	261	GAC	525	527	GAC	51;52;51	G;A;C	48;48;51	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2852	gyrA_7	2628	2628	98.71	gyrA_7.l15.c17.ctg.1	3113	49.1	1	SNP	p	D87H	0	.	.	259	261	GAC	525	527	GAC	51;52;51	G;A;C	48;48;51	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3044	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2948	55.3	1	SNP	p	R136S	0	.	.	406	408	CGC	671	673	CGC	44;43;42	C;G;C	44;43;42	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3044	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2948	55.3	1	SNP	p	R136H	0	.	.	406	408	CGC	671	673	CGC	44;43;42	C;G;C	44;43;42	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3044	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2948	55.3	1	SNP	p	R136G	0	.	.	406	408	CGC	671	673	CGC	44;43;42	C;G;C	44;43;42	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3044	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2948	55.3	1	SNP	p	R136E	0	.	.	406	408	CGC	671	673	CGC	44;43;42	C;G;C	44;43;42	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3044	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2948	55.3	1	SNP	p	R136C	0	.	.	406	408	CGC	671	673	CGC	44;43;42	C;G;C	44;43;42	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3044	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2948	55.3	1	SNP	p	R136L	0	.	.	406	408	CGC	671	673	CGC	44;43;42	C;G;C	44;43;42	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3044	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2948	55.3	1	SNP	p	R136I	0	.	.	406	408	CGC	671	673	CGC	44;43;42	C;G;C	44;43;42	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	506	kdpE	678	678	98.08	kdpE.l6.c4.ctg.1	1067	25.4	0	.	p	.	0	A72P	NONSYN	214	216	GCG	428	430	CCG	37;39;40	C;C;G	36;39;40	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	506	kdpE	678	678	98.08	kdpE.l6.c4.ctg.1	1067	25.4	0	.	p	.	0	T123A	NONSYN	367	369	ACC	581	583	GCC	27;26;24	G;C;C	23;25;23	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	1230	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1447	45.5	0	.	p	.	0	P9S	NONSYN	25	27	CCA	231	233	TCA	43;42;41	T;C;A	43;41;40	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	286	marA	384	384	99.74	marA.l15.c4.ctg.1	807	18.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	204	marR	435	435	97.47	marR.l6.c4.ctg.1	661	16.1	0	.	p	.	0	L87S	NONSYN	259	261	TTG	472	474	TCG	2;2;3	T;C,T;G	2;0,1;3	.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	204	marR	435	435	97.47	marR.l6.c4.ctg.1	661	16.1	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	520	522	AGC	23;23;24	A;G;C	23;23;24	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	204	marR	435	435	97.47	marR.l6.c4.ctg.1	661	16.1	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	622	624	CAT	12;10;10	C;A;T	10;9;10	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	204	marR	435	435	97.47	marR.l6.c4.ctg.1	661	16.1	1	SNP	p	V45E	0	.	.	133	135	GTG	346	348	GTG	36;36;35	G;T;G	36;36;35	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	204	marR	435	435	97.47	marR.l6.c4.ctg.1	661	16.1	1	SNP	p	I49S	0	.	.	145	147	ATC	358	360	ATC	36;35;34	A;T;C	36;35;34	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	204	marR	435	435	97.47	marR.l6.c4.ctg.1	661	16.1	1	SNP	p	A70T	0	.	.	208	210	GCA	421	423	GCA	21;21;21	G;C;A	21;21;21	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	204	marR	435	435	97.47	marR.l6.c4.ctg.1	661	16.1	1	SNP	p	R73S	0	.	.	217	219	CGT	430	432	CGT	19;19;19	C;G;T	19;19;19	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	204	marR	435	435	97.47	marR.l6.c4.ctg.1	661	16.1	1	SNP	p	R73C	0	.	.	217	219	CGT	430	432	CGT	19;19;19	C;G;T	19;19;19	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	204	marR	435	435	97.47	marR.l6.c4.ctg.1	661	16.1	1	SNP	p	R77L	0	.	.	229	231	CGC	442	444	CGC	15;14;14	C;G;C	15;14;14	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	204	marR	435	435	97.47	marR.l6.c4.ctg.1	661	16.1	1	SNP	p	R77C	0	.	.	229	231	CGC	442	444	CGC	15;14;14	C;G;C	15;14;14	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	204	marR	435	435	97.47	marR.l6.c4.ctg.1	661	16.1	1	SNP	p	L78M	0	.	.	232	234	CTG	445	447	CTG	14;13;13	C;T;G	14;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	204	marR	435	435	97.47	marR.l6.c4.ctg.1	661	16.1	1	SNP	p	R94S	0	.	.	280	282	CGC	493	495	CGC	9;9;9	C;G;C	9;9;9	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	204	marR	435	435	97.47	marR.l6.c4.ctg.1	661	16.1	1	SNP	p	R94H	0	.	.	280	282	CGC	493	495	CGC	9;9;9	C;G;C	9;9;9	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	204	marR	435	435	97.47	marR.l6.c4.ctg.1	661	16.1	1	SNP	p	V96E	0	.	.	286	288	GTA	499	501	GTA	12;12;13	G;T;A	12;12;13	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	784	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1456	28.3	0	.	p	.	0	S7F	NONSYN	19	21	TCC	45	47	TTC	5;5;5	T;T;C	5;5;5	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	784	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1456	28.3	0	.	p	.	0	R36I	NONSYN	106	108	AGG	132	134	ATC	18;18;18	A;T;C	18;18;18	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	784	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1456	28.3	0	.	p	.	0	E42A	NONSYN	124	126	GAA	150	152	GCC	9;9;9	G;C;C	9;9;9	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	784	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1456	28.3	0	.	p	.	0	N43V	NONSYN	127	129	AAT	153	155	GTG	9;9;9	G;T;G	9;9;9	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	784	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1456	28.3	0	.	p	.	0	E52D	NONSYN	154	156	GAG	180	182	GAT	17;17;17	G;A;T	17;16;17	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	784	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1456	28.3	0	.	p	.	0	N59T	NONSYN	175	177	AAC	201	203	ACC	17;17;17	A;C;C	17;17;16	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	784	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1456	28.3	0	.	p	.	0	I68L	NONSYN	202	204	ATA	228	230	TTA	17;15;16	T;T;A	17;15;16	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	784	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1456	28.3	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	369	371	CAG	56;56;54	C;A,G;G	55;55,1;54	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	784	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1456	28.3	0	.	p	.	0	D128A	NONSYN	382	384	GAC	408	410	GCC	32;31;30	G;C;C	31;31;30	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	784	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1456	28.3	0	.	p	.	0	S163A	NONSYN	487	489	TCG	513	515	GCG	20;22;22	G;C;G	19;21;21	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	784	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1456	28.3	0	.	p	.	0	L231V	NONSYN	691	693	CTT	717	719	GTT	17;18;19	G;T;T	12;15;16	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	784	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1456	28.3	0	.	p	.	0	R285fs	FSHIFT	853	853	C	879	879	C	26	C,G	25,1	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	820	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1711	25.7	0	.	p	.	0	V12trunc	TRUNC	34	34	G	297	297	G	31	G	31	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	820	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1711	25.7	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	354	356	CAG	20;19;18	C;A;G	20;19;18	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	820	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1711	25.7	0	.	p	.	0	T83I	NONSYN	247	249	ACC	504	506	ATC	26;25;24	A;T;C	26;25;24	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	820	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1711	25.7	0	.	p	.	0	I99M	NONSYN	295	297	ATA	552	554	ATG	15;15;17	A;T;G	15;15;17	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	820	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1711	25.7	0	.	p	.	0	A130T	NONSYN	388	390	GCC	645	647	ACC	20;20;21	A;C;C	20;20;21	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3088	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3451	47.9	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1967	1969	ACC	49;49;49	A;C;C	49;49;49	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3088	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3451	47.9	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2360	2362	CAA	31;33;36	C;A;A	30;33;35	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3088	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3451	47.9	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2528	2530	ATT	32;31;32	A;T;T	32;31;31	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3088	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3451	47.9	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2612	2614	GTT	46;44;49	G;T,C;T	46;43,1;49	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3088	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3451	47.9	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2720	2722	GAG	34;33;32	G;A;G	34;33;32	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3088	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3451	47.9	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2948	2950	ATG	28;28;30	A;T;G	28;28;30	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3088	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3451	47.9	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3083	3085	GAT	29;29;28	G;A;T	29;28;28	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2686	mdtC	3078	3078	98.7	mdtC.l6.c4.ctg.1	3480	41.2	0	.	p	.	0	I46M	NONSYN	136	138	ATC	323	325	ATG	27;27;27	A;T;G	26;26;26	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2686	mdtC	3078	3078	98.7	mdtC.l6.c4.ctg.1	3480	41.2	0	.	p	.	0	V208I	NONSYN	622	624	GTC	809	811	ATC	49;50;51	A;T;C	48;50;51	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2686	mdtC	3078	3078	98.7	mdtC.l6.c4.ctg.1	3480	41.2	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3125	3127	CAC	5;5;5	C;A;C	5;5;5	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1214	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1766	36.5	0	.	p	.	0	D3E	NONSYN	7	9	GAT	169	171	GAA	22;22;22	G;A;A	22;22;22	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1214	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1766	36.5	0	.	p	.	0	T226A	NONSYN	676	678	ACG	838	840	GCG	38;37;39	G;C;G	38;37;39	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1214	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1766	36.5	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1180	1182	ATC	39;39;40	A;T;C	39;39;40	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1214	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1766	36.5	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1483	1485	TTT	45;45;46	T;T;T	45;45;46	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1604	mdtE	1158	1158	99.31	mdtE.l15.c17.ctg.1	1641	52.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3984	mdtF	3114	3114	98.52	mdtF.l6.c17.ctg.1	3632	58.8	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1142	1144	ACC	37;37;39	A;C,A;C	37;33,2;39	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3984	mdtF	3114	3114	98.52	mdtF.l6.c17.ctg.1	3632	58.8	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2384	2386	GAC	67;68;69	G;A,G;C	66;67,1;69	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1068	mdtG	1227	1047	99.43	mdtG.l15.c4.ctg.2	1522	30.2	0	.	p	.	0	V200I	NONSYN	598	600	GTC	680	682	ATC	39;40;41	A;T;C	39;40;41	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1068	mdtG	1227	177	99.44	mdtG.l15.c4.ctg.4	187	29.7	0	.	p	.	0	E5G	NONSYN	13	15	GAA	8	10	GGA	10;10;10	G;G;A	10;10;10	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	838	mdtH	1209	1209	98.1	mdtH.l15.c30.ctg.1	1375	31.8	0	.	p	.	0	G134C	NONSYN	400	402	GGT	406	408	TGT	34;37;38	T;G;T	34;37;38	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	838	mdtH	1209	1209	98.1	mdtH.l15.c30.ctg.1	1375	31.8	0	.	p	.	0	S324L	NONSYN	970	972	TCG	976	978	TTG	30;29;29	T;T;G	30;29;29	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	838	mdtH	1209	1209	98.1	mdtH.l15.c30.ctg.1	1375	31.8	0	.	p	.	0	L359Q	NONSYN	1075	1077	CTG	1081	1083	CAG	17;17;20	C;A;G	17;17;20	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	838	mdtH	1209	1209	98.1	mdtH.l15.c30.ctg.1	1375	31.8	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1186	1188	ACG	14;15;16	A;C;G	14;15;16	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1486	mdtL	1176	1176	98.47	mdtL.l15.c4.ctg.1	1649	48.4	0	.	p	.	0	A185S	NONSYN	553	555	GCC	801	803	TCC	35;34;32	T;C;C	34;34;32	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	888	mdtN	1032	1032	98.16	mdtN.l15.c17.ctg.1	1464	32.4	0	.	p	.	0	V119I	NONSYN	355	357	GTT	556	558	ATT	30;28;29	A;T;T	30;28;29	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2386	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2465	51.7	0	.	p	.	0	V11M	NONSYN	31	33	GTG	187	189	ATG	23;24;24	A;T;G	23;24;24	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2386	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2465	51.7	0	.	p	.	0	T33I	NONSYN	97	99	ACC	253	255	ATC	24;24;24	A;T;C	24;23;24	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2386	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2465	51.7	0	.	p	.	0	C116R	NONSYN	346	348	TGC	502	504	CGC	57;54;57	C;G;C	57;54;56	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2386	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2465	51.7	0	.	p	.	0	N238S	NONSYN	712	714	AAC	868	870	AGC	63;62;62	A;G;C	63;62;62	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2386	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2465	51.7	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1069	1071	GTG	50;54;55	G;T;G	50;51;55	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2386	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2465	51.7	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1132	1134	AAC	19;17;18	A;A;C	19;16;17	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2386	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2465	51.7	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1177	1179	GTC	48;48;51	G;T,C;C	47;47,1;50	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2386	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2465	51.7	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1207	1209	ATA	73;75;73	A;T;A	73;75;73	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2386	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2465	51.7	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1315	1317	TCT	40;41;43	T;C;T	40;41;43	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2386	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2465	51.7	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1702	1704	GCG	63;62;63	G;C;G	63;59;63	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2386	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2465	51.7	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1915	1917	ATC	72;70;69	A;T;C	72;70;69	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1324	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1931	36.7	0	.	p	.	0	S129A	NONSYN	385	387	TCA	659	661	GCG	45;41;43	G;C;G	45;41;43	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1324	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1931	36.7	0	.	p	.	0	A187T	NONSYN	559	561	GCC	833	835	ACC	39;40;40	A;C;C	38;40;40	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1324	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1931	36.7	0	.	p	.	0	H211R	NONSYN	631	633	CAC	905	907	CGC	39;37;38	C;G;C	39;37;38	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1324	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1931	36.7	0	.	p	.	0	V250A	NONSYN	748	750	GTT	1022	1024	GCT	35;33;35	G;C;T	35;31;35	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1324	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1931	36.7	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1106	1108	AAA	20;19;19	A;A;A	20;19;19	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1324	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1931	36.7	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1124	1126	CGA	19;21;23	C;G;A	19;21;22	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1324	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1931	36.7	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1289	1291	GCC	30;30;30	G;C;C	30;30;30	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1324	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1931	36.7	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1301	1303	GAT	31;32;32	G;A;T	31;32;32	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1324	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1931	36.7	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1718	1720	GCT	17;17;16	G;C;T	17;16;16	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3074	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3898	42.2	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1504	1506	AAG	23;23;23	A;A;G	22;23;23	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3074	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3898	42.2	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2581	2583	CTG	63;63;61	C;T;G	63;62;61	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	198	mgrB	144	144	100.0	mgrB.l15.c4.ctg.2	162	32.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1942	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2174	47.9	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1035	1037	AAC	47;47;49	A;A;C	47;47;49	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1942	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2174	47.9	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1581	1583	ATA	75;76;75	A;T;A	75;76;74	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	1702	murA_12	1260	1260	98.49	murA_12.l6.c30.ctg.1	1720	53.1	0	.	p	.	0	A343V	NONSYN	1027	1029	GCG	1270	1272	GTG	60;60;58	G;T;G	60;58;58	.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	1702	murA_12	1260	1260	98.49	murA_12.l6.c30.ctg.1	1720	53.1	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1348	1350	GAT	78;75;76	G;A;T	78;75;74	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	1702	murA_12	1260	1260	98.49	murA_12.l6.c30.ctg.1	1720	53.1	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1351	1353	CTG	74;76;75	C;T;G	73;75;75	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	528	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1191	23.8	0	.	p	.	0	R27C	NONSYN	79	81	CGT	315	317	TGT	33;34;32	T;G;T	33;34;32	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	528	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1191	23.8	0	.	p	.	0	I117T	NONSYN	349	351	ATC	585	587	ACC	40;41;41	A;C;C	39;41;40	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	528	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1191	23.8	0	.	p	.	0	G187D	NONSYN	559	561	GGC	795	797	GAC	21;20;19	G;A;C	21;20;19	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	528	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1191	23.8	1	SNP	p	R15C	0	.	.	43	45	CGC	279	281	CGC	43;43;42	C;G;C	43;43;42	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	528	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1191	23.8	1	SNP	p	S33R	0	.	.	97	99	AGC	333	335	AGC	37;36;36	A;G;C	37;36;36	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	528	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1191	23.8	1	SNP	p	G131D	0	.	.	391	393	GGC	627	629	GGC	34;34;34	G;G;C	34;34;30	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	528	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1191	23.8	1	SNP	p	R203L	0	.	.	607	609	CGT	843	845	CGT	27;26;25	C;G;T	27;26;25	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	528	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1191	23.8	1	SNP	p	R203C	0	.	.	607	609	CGT	843	845	CGT	27;26;25	C;G;T	27;26;25	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	1384	ompF	1089	1089	100.0	ompF.l6.c4.ctg.1	1530	48.4	1	SNP	p	G141E	0	.	.	421	423	GGT	639	641	GGT	73;75;76	G;G;T	73;75;76	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	1384	ompF	1089	1089	100.0	ompF.l6.c4.ctg.1	1530	48.4	1	SNP	p	G141D	0	.	.	421	423	GGT	639	641	GGT	73;75;76	G;G;T	73;75;76	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	1384	ompF	1089	1089	100.0	ompF.l6.c4.ctg.1	1530	48.4	1	SNP	p	R154D	0	.	.	460	462	CGT	678	680	CGT	76;78;79	C;G;T	75;78;79	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	1384	ompF	1089	1089	100.0	ompF.l6.c4.ctg.1	1530	48.4	1	SNP	p	R154A	0	.	.	460	462	CGT	678	680	CGT	76;78;79	C;G;T	75;78;79	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2866	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2710	56.7	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1873	1875	TCG	82;83;79	T;C;G	80;82;79	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2866	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2710	56.7	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2488	2490	AAC	45;43;42	A;A;C	45;43;42	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2866	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2710	56.7	1	SNP	p	A85T	0	.	.	253	255	GCG	502	504	GCG	55;54;54	G;C,G;G	55;51,1;52	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2866	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2710	56.7	1	SNP	p	D111H	0	.	.	331	333	GAT	580	582	GAT	51;53;54	G;A;T	51;53;54	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2866	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2710	56.7	1	SNP	p	S129P	0	.	.	385	387	TCC	634	636	TCC	70;67;66	T;C;C	70;66;66	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	27	1750	parE_1	1893	1893	97.57	parE_1.l6.c17.ctg.1	2500	37.5	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1732	1734	GAT	72;72;72	G;A;T	72;72;72	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1564	patA	1380	1380	99.86	patA.l6.c30.ctg.1	1847	45.2	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1294	1296	GAT	48;49;50	G;A;T	48;49;50	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6168	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4555	72.6	1	SNP	p	V146F	0	.	.	436	438	GTT	676	678	GTT	64;64;63	G;T;T	64;64;63	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6168	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4555	72.6	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1777	1779	CAG	85;84;85	C;A;G	85;84;85	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6168	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4555	72.6	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1777	1779	CAG	85;84;85	C;A;G	85;84;85	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6168	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4555	72.6	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1816	1818	CAC	70;72;74	C;A;C	70;72;74	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6168	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4555	72.6	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1825	1827	CGT	68;68;68	C;G;T	68;68;68	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6168	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4555	72.6	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1825	1827	CGT	68;68;68	C;G;T	68;68;68	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6168	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4555	72.6	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1831	1833	TCC	67;64;63	T;C;C	67;64;63	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6168	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4555	72.6	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1837	1839	CTC	58;59;59	C;T;C	58;59;59	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6168	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4555	72.6	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1927	1929	ACC	74;75;74	A;C;C	73;74;73	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6168	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4555	72.6	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1930	1932	CCT	73;73;73	C;C;T	72;72;73	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6168	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4555	72.6	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2299	2301	CGT	143;142;139	C;G;T	142;141;139	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	A406G	SNP	406	406	A	650	650	G	474	G	468	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	A410G	SNP	410	410	A	654	654	G	479	G	478	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	T412C	SNP	412	412	T	656	656	C	487	C	484	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	A508G	SNP	508	508	A	752	752	G	419	G,A	314,105	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	C522.	DEL	522	522	C	765	765	A	426	A	426	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	A525T	SNP	525	525	A	768	768	T	395	T,A	314,4	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	.527T	INS	527	527	C	771	771	T	321	T	321	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	G536A	SNP	536	536	G	780	780	A	449	A,G	322,125	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	G540C	SNP	540	540	G	784	784	C	444	C,G	317,126	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	T544C	SNP	544	544	T	788	788	C	430	C,T	309,121	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	T670G	SNP	670	670	T	914	914	G	404	G	397	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	A722C	SNP	722	722	A	966	966	C	387	C	385	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	T801C	SNP	801	801	T	1045	1045	C	383	C	382	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	A886G	SNP	886	886	A	1130	1130	G	406	G	401	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	C897T	SNP	897	897	C	1141	1141	T	418	T,C	417,1	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	T905A	SNP	905	905	T	1149	1149	A	397	A	396	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	A909G	SNP	909	909	A	1153	1153	G	386	G	384	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	C946T	SNP	946	946	C	1190	1190	T	413	T	411	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	G952A	SNP	952	952	G	1196	1196	A	407	A	406	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	G956A	SNP	956	956	G	1200	1200	A	409	A,G,T	407,1,1	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	.1068G	INS	1068	1068	T	1313	1313	G	452	G	444	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	T1069A	SNP	1069	1069	T	1314	1314	A	446	A	442	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	C1074A	SNP	1074	1074	C	1319	1319	A	452	A	452	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	T1077.	DEL	1077	1077	T	1321	1321	G	454	G	452	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	A1086T	SNP	1086	1086	A	1330	1330	T	463	T	460	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	A1089C	SNP	1089	1089	A	1333	1333	C	470	C	465	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	A1091C	SNP	1091	1091	A	1335	1335	C	484	C	480	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	T1273A	SNP	1273	1273	T	1517	1517	A	382	A,T	285,91	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	T1288C	SNP	1288	1288	T	1532	1532	C	440	C,G	437,1	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	A1293T	SNP	1293	1293	A	1537	1537	T	413	T,A	316,94	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	A1296T	SNP	1296	1296	A	1540	1540	T	423	T,A,C	323,94,2	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	.	n	.	0	T1320C	SNP	1320	1320	T	1564	1564	C	477	C	475	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	1	SNP	n	C1065T	0	.	.	1065	1065	C	1309	1309	C	448	C	441	rrsD.3003512.AE006468.3570463_3572006.3227:0:0:C1065T:.:Point mutations in the helix 34 region of the rrsD 16S rRNA gene of Salmonella enterica serovar Typhimurium can confer resistance to spectinomycin	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	1	SNP	n	C1192T	0	.	.	1192	1192	C	1436	1436	C	451	C	448	rrsD.3003512.AE006468.3570463_3572006.3227:0:0:C1192T:.:Point mutations in the helix 34 region of the rrsD 16S rRNA gene of Salmonella enterica serovar Typhimurium can confer resistance to spectinomycin	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	HET	.	.	.	C1071T	.	1071	1071	C	1316	1316	C	433	C,T	333,93	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	1351	97.12	rrsB+.l15.c30.ctg.1	1595	403.8	0	HET	.	.	.	G827A	.	827	827	G	1071	1071	G	354	G,A	214,140	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	180	98.33	rrsB+.l15.c30.ctg.2	322	283.1	0	.	n	.	0	C1379T	SNP	1379	1379	C	15	15	T	344	T	163	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	180	98.33	rrsB+.l15.c30.ctg.2	322	283.1	0	.	n	.	0	G1456A	SNP	1456	1456	G	92	92	A	393	A,G	306,84	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
rrsD.3003512.AE006468.3570463_3572006.3227	rrsD.3003512.AE006468.3570463_3572006.3227	0	0	641	14310	rrsB+	1544	180	98.33	rrsB+.l15.c30.ctg.2	322	283.1	0	.	n	.	0	C1467T	SNP	1467	1467	C	103	103	T	396	T,C	293,100	.	Salmonella enterica serovar Typhimurium 16S rRNA mutation in the rrsD gene conferring resistance to spectinomycin
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	480	soxS_1	324	324	99.69	soxS_1.l15.c30.ctg.1	860	30.0	1	SNP	p	A12S	0	.	.	34	36	GCA	288	290	GCA	62;64;66	G;C;A,C	62;64;65,1	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1982	tolC	1488	1488	98.72	tolC.l15.c30.ctg.1	1973	53.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
